Davide Rapezzi

2.0k total citations
14 papers, 133 citations indexed

About

Davide Rapezzi is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Davide Rapezzi has authored 14 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Davide Rapezzi's work include Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Davide Rapezzi is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Davide Rapezzi collaborates with scholars based in Italy and France. Davide Rapezzi's co-authors include Anna Maria Ferraris, Rosa Mangerini, Omar Racchi, Gian Franco Gaetani, Michela Rolfo, Salvatore Casciaro, Andrea Gallamini, Federico Simonetti, Fontanet Bijou and Tamara Intermesoli and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Davide Rapezzi

13 papers receiving 130 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Davide Rapezzi Italy	7	58	54	37	25	22	14	133
María Elena Mateos Spain	7	23 0.4×	17 0.3×	27 0.7×	22 0.9×	16 0.7×	16	126
Mikko Myllymäki Finland	8	29 0.5×	36 0.7×	40 1.1×	15 0.6×	25 1.1×	14	127
Gavin Cuthbert United Kingdom	8	97 1.7×	58 1.1×	59 1.6×	56 2.2×	8 0.4×	13	173
Su Li Poh Singapore	7	33 0.6×	13 0.2×	56 1.5×	17 0.7×	8 0.4×	8	225
Maria Pina Simula Italy	6	64 1.1×	21 0.4×	19 0.5×	15 0.6×	24 1.1×	14	194
Heike Rübsamen Germany	5	97 1.7×	11 0.2×	81 2.2×	10 0.4×	19 0.9×	8	255
Jacinth Joseph United States	6	64 1.1×	60 1.1×	52 1.4×	6 0.2×	11 0.5×	16	179
Hilda Rachel Diamond Brazil	6	104 1.8×	13 0.2×	42 1.1×	10 0.4×	22 1.0×	11	291
Ramiro Núñez Spain	11	174 3.0×	46 0.9×	47 1.3×	11 0.4×	53 2.4×	39	276
M. De Arce Ireland	7	41 0.7×	22 0.4×	36 1.0×	38 1.5×	6 0.3×	7	181

Countries citing papers authored by Davide Rapezzi

Since Specialization

Citations

This map shows the geographic impact of Davide Rapezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Rapezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Rapezzi more than expected).

Fields of papers citing papers by Davide Rapezzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Rapezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Rapezzi. The network helps show where Davide Rapezzi may publish in the future.

Co-authorship network of co-authors of Davide Rapezzi

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Rapezzi. A scholar is included among the top collaborators of Davide Rapezzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Rapezzi. Davide Rapezzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mannelli, Francesco, Roberta Zanotti, Livio Pagano, et al.. (2023). The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Therapeutic Advances in Hematology. 14. 1564123403–1564123403.

Benevolo, Giulia, Monia Marchetti, Remo Melchio, et al.. (2023). Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera. Vascular Health and Risk Management. Volume 19. 765–778. 5 indexed citations

Borgogna, Cinzia, Riccardo Bruna, Gloria Griffante, et al.. (2022). Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients. Blood Cancer Journal. 12(1). 8–8. 5 indexed citations

Guida, Giuseppe, et al.. (2022). Cutaneous allergic reaction correlates with anti‐erythropoietin antibodies in dialysis patient developing pure red cell aplasia. SHILAP Revista de lepidopterología. 10(4). e05554–e05554. 3 indexed citations

Castellino, Alessia, Roberto Sorasio, Claudia Castellino, et al.. (2021). Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases. SHILAP Revista de lepidopterología. 9(3). 1066–1071. 1 indexed citations

Castellino, Alessia, et al.. (2021). Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment. Medicina. 57(10). 1104–1104. 3 indexed citations

Castellino, Alessia, Claudia Castellino, Margherita Bonferroni, et al.. (2020). Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports. Journal of Medical Case Reports. 14(1). 75–75. 6 indexed citations

Colella, Jean‐Marc Schiano de, Simonetta Viviani, Davide Rapezzi, et al.. (2020). Brentuximab vedotin and bendamustine as first-line treatment of Hodgkin lymphoma in the elderly (HALO Trial).. Journal of Clinical Oncology. 38(15_suppl). 8029–8029. 8 indexed citations

Graffigna, Guendalina, Massimo Breccia, Enrico Capochiani, et al.. (2017). Recovering from chronic myeloid leukemia: the patients’ perspective seen through the lens of narrative medicine. Quality of Life Research. 26(10). 2739–2754. 20 indexed citations

10.

Sorasio, Roberto, Margherita Bonferroni, Mariella Grasso, et al.. (2014). Peripheral Blood CD34+ Percentage at Hematological Recovery after Chemotherapy Is a Good Early Predictor of Harvest: A Single-Center Experience. Biology of Blood and Marrow Transplantation. 20(5). 717–723. 10 indexed citations

11.

Ferraris, Anna Maria, Rosa Mangerini, Davide Rapezzi, et al.. (2005). Clonal granulocytes in polycythaemia vera and essential thrombocythaemia have shortened telomeres. British Journal of Haematology. 130(3). 391–393. 7 indexed citations

12.

Ferraris, Anna Maria, Rosa Mangerini, Omar Racchi, et al.. (2004). High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia. Blood. 105(5). 2138–2140. 15 indexed citations

13.

Ferraris, Anna Maria, Rosa Mangerini, Omar Racchi, et al.. (1999). Heterogeneity of clonal development in chronic myeloproliferative disorders. American Journal of Hematology. 60(2). 158–160. 10 indexed citations

14.

Racchi, Omar, Rosa Mangerini, Davide Rapezzi, et al.. (1998). X Chromosome Inactivation Patterns in Normal Females. Blood Cells Molecules and Diseases. 24(4). 439–447. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact